1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Serum C-peptide level and the risk of cardiovascular diseases mortality and all-cause mortality: a meta-analysis and systematic review

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Aims and background

          Recently, the serum of C-peptide has been the focus of researchers as a possible predictor of mortality. However, the possible association of serum C-peptide with cardiovascular diseases (CVDs) mortality and all-cause mortality has not been clearly identified. This meta-analysis aimed to assess the relationship between serum C-peptide and the risk of CVDs mortality and all-cause mortality.

          Methods

          A comprehensive and systematic search was performed in various important databases, including the PubMed, Web of Science, and Scopus to find relevant studies up to November 2022. The reported hazard ratio (HR) [95% confidence interval (CI)] for all studies was converted into log HR, and their SD was calculated. Then to compute the pooled HR, the random-effects model with inverse variance weighting method was performed.

          Results

          Twenty-three studies were included in the meta-analysis. Fourteen studies reported HR for all-cause mortality, and nine studies for CVDs-related mortality. The pooled results indicate a significant association between serum C-peptide and the risk of all-cause mortality (HR: 1.22; 95% CI: 1.12–1.32, I 2 = 76.8%; P-value < 0.001). Also, higher serum C-peptide was related to the increased risk of CVDs mortality (HR: 1.38; 95% CI: 1.08–1.77, I 2 = 81.8%; P-value = 0.012).

          Conclusions

          Our investigation suggested that an increased level of serum C-peptide is associated with a higher risk of both CVDs and all-cause mortality. Further, large-scale studies and sufficient samples are recommended to present a convincing link between C-peptide and the risk of CVDs and all-cause mortality.

          Systematic Review Registration

          identifier, CRD42022364842.

          Related collections

          Most cited references47

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

          Systematic reviews should build on a protocol that describes the rationale, hypothesis, and planned methods of the review; few reviews report whether a protocol exists. Detailed, well-described protocols can facilitate the understanding and appraisal of the review methods, as well as the detection of modifications to methods and selective reporting in completed reviews. We describe the development of a reporting guideline, the Preferred Reporting Items for Systematic reviews and Meta-Analyses for Protocols 2015 (PRISMA-P 2015). PRISMA-P consists of a 17-item checklist intended to facilitate the preparation and reporting of a robust protocol for the systematic review. Funders and those commissioning reviews might consider mandating the use of the checklist to facilitate the submission of relevant protocol information in funding applications. Similarly, peer reviewers and editors can use the guidance to gauge the completeness and transparency of a systematic review protocol submitted for publication in a journal or other medium.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Quantifying heterogeneity in a meta-analysis.

            The extent of heterogeneity in a meta-analysis partly determines the difficulty in drawing overall conclusions. This extent may be measured by estimating a between-study variance, but interpretation is then specific to a particular treatment effect metric. A test for the existence of heterogeneity exists, but depends on the number of studies in the meta-analysis. We develop measures of the impact of heterogeneity on a meta-analysis, from mathematical criteria, that are independent of the number of studies and the treatment effect metric. We derive and propose three suitable statistics: H is the square root of the chi2 heterogeneity statistic divided by its degrees of freedom; R is the ratio of the standard error of the underlying mean from a random effects meta-analysis to the standard error of a fixed effect meta-analytic estimate, and I2 is a transformation of (H) that describes the proportion of total variation in study estimates that is due to heterogeneity. We discuss interpretation, interval estimates and other properties of these measures and examine them in five example data sets showing different amounts of heterogeneity. We conclude that H and I2, which can usually be calculated for published meta-analyses, are particularly useful summaries of the impact of heterogeneity. One or both should be presented in published meta-analyses in preference to the test for heterogeneity. Copyright 2002 John Wiley & Sons, Ltd.
              Bookmark
              • Record: found
              • Abstract: not found
              • Book: not found

              Cochrane Handbook for Systematic Reviews of Interventions

                Bookmark

                Author and article information

                Contributors
                Journal
                Front Cardiovasc Med
                Front Cardiovasc Med
                Front. Cardiovasc. Med.
                Frontiers in Cardiovascular Medicine
                Frontiers Media S.A.
                2297-055X
                07 July 2023
                2023
                : 10
                : 1205481
                Affiliations
                [ 1 ]Nutrition and Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences , Tehran, Iran
                [ 2 ]Department of Nutrition, School of Public Health, Iran University of Medical Sciences , Tehran, Iran
                [ 3 ]Department of Community Nutrition, School of Nutrition and Food Sciences, Shiraz University of Medical Sciences , Shiraz, Iran
                [ 4 ]Endocrinology and Metabolism Research Center, Hormozgan University of Medical Sciences , BandarAbbas, Iran
                Author notes

                Edited by: Gen-Min Lin, Hualien Armed Forces General Hospital, Taiwan

                Reviewed by: Hadith Rastad, Alburz University of Medical Sciences, Iran Hojat Dehghanbanadaki, Tehran University of Medical Sciences, Iran

                [* ] Correspondence: Hossein Farhadnejad hosein.farhadnejad@ 123456gmail.com Parvin Mirmiran mirmiran@ 123456endocrine.ac.ir
                [ † ]

                These authors have contributed equally to this work and share first authorship

                Article
                10.3389/fcvm.2023.1205481
                10360119
                37485272
                39997462-6e1c-44c2-b09b-c3391686ad14
                © 2023 Ahmadirad, Teymoori, Mokhtari, Jahromi, Norouzzadeh, Tavakkoli, Shahrokhtabar, Farhadnejad and Mirmiran.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 14 April 2023
                : 23 June 2023
                Page count
                Figures: 2, Tables: 4, Equations: 0, References: 48, Pages: 0, Words: 0
                Funding
                Funded by: Research Institute of Endocrine Sciences
                Award ID:  
                Funded by: Shahid Beheshti University Medical Sciences, Tehran, Iran
                Award ID:  
                This study was supported by the Research Institute of Endocrine Sciences, Shahid Beheshti University Medical Sciences, Tehran, Iran.
                Categories
                Cardiovascular Medicine
                Systematic Review
                Custom metadata
                Cardiovascular Epidemiology and Prevention

                cardiovascular diseases mortality,all-cause mortality,mortality,c-peptide,meta-analysis

                Comments

                Comment on this article